CD276 and neoplasm: In this study, only ES4-WT tumors on the right flank could be completely eradicated by the ADC, while the ES4-KO tumors on the left flank exhibited a partial response, presumably due to ADC targeting of CD276+ tumor-associated stromal cells (Figure 3E).